AI boosts Low-Dose brain scans, cutting contrast agent by up to 90%
Diagnosis
Completed
This study tested whether artificial intelligence (AI) can enhance brain MRI images taken with a much lower dose of gadobutrol contrast agent, making them as clear as standard-dose images. Sixty adults with known or suspected brain lesions received either a low dose (10% or 25% o…
Phase: PHASE1 • Sponsor: Subtle Medical • Aim: Diagnosis
Last updated May 12, 2026 13:41 UTC